Avery Therapeutics Inc.

Tucson, AZ

UEI
EAEKFAHSBLQ1
CAGE
73GT3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2500 N Tucson Blvd #140, Tucson, AZ 85716, USA
Website
averythera.com
Founded
2016
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development and assessment of an engineered cardiac tissue for treating dilated cardiomyopathy R43HL144332 National Heart Lung and Blood Institute (NIH) $299,998
HLS16-07: manufacturing tissue engineered patch to treat heart failure R43HL132673 National Institutes of Health $483,960

Quick answers

Is Avery Therapeutics Inc. registered in SAM.gov?

Yes. Avery Therapeutics Inc.'s SAM.gov registration is active through September 15, 2027.

What is Avery Therapeutics Inc.'s most recent federal award?

Avery Therapeutics Inc.'s most recent federal grant award is Development and assessment of an engineered cardiac tissue for treating dilated cardiomyopathy (R43HL144332), from National Heart Lung and Blood Institute (NIH), on May 15, 2019.

On GovTribe

See Avery Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login